Moxalactam Plus Ticarcillin or Tobramycin for Treatment of Febrile Episodes in Neutropenic Cancer Patients

作者: Victor Fainstein

DOI: 10.1001/ARCHINTE.1984.00350210078014

关键词:

摘要: • Moxalactam disodium In combination with ticarcillin or tobramycin sulfate was used to treat 445 episodes of suspected confirmed infection patients cancer. The majority had leukemia and neutropenla. rate cures during the 231 infections 65% for moxalactam 64% tobramycin. Both regimens were comparable agalpst aerobic gram-negative polymicrobial Infections. gram-positive infections, response 73% tobramycin, 53%. Only three nine enterococcal Infections responded treatment. Thirteen percent all organisms recovered resistant moxalactam. Side effects occurred infrequently; most important coagulopathy due Nephrotoxic in six receiving none those ticarcillin. 39 patients, a superinfection confirmed. Fourteen fungal, enterococcus, one toKlebsiellaspecies. Eleven 14 fungal moxalactamticarcillin group. are equally active Initial treatment presumed neutropenia. (Arch Intern Med1984;144:1766-1770)

参考文章(26)
Robert K. Stuart, Hayden G. Braine, Paul S. Lietman, Rein Saral, Donald J. Fuller, Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients The American Journal of Medicine. ,vol. 68, pp. 876- 885 ,(1980) , 10.1016/0002-9343(80)90217-X
Carlos A De Jongh, James C Wade, Stephen C Schimpff, Kathryn A Newman, Rececca S Finley, Paula C Salvatore, Marcia R Moody, Harold C Standiford, Clarence L Fortner, Peter H Wiernik, Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: A Comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin The American Journal of Medicine. ,vol. 73, pp. 89- 96 ,(1982) , 10.1016/0002-9343(82)90935-4
Gerald P. Bodey, Carbenicillin Therapy for Pseudomonas Infections JAMA: The Journal of the American Medical Association. ,vol. 218, pp. 62- 66 ,(1971) , 10.1001/JAMA.1971.03190140038007
GERALD P. BODEY, MANUEL VALDIVIESO, RONALD FELD, VICTORIO RODRIGUEZ, KENNETH McCREDIE, Carbenicillin plus cephalothin or cefazolin as therapy for infections in neutropenic patients. The American Journal of the Medical Sciences. ,vol. 273, pp. 309- 318 ,(1977) , 10.1097/00000441-197705000-00009
Drew J Winston, Winston G Ho, Lowell S Young, William L Hewitt, Robert P Gale, Piperacillin Plus Amikacin Therapy v Carbenicillin Plus Amikacin Therapy in Febrile, Granulocytopenic Patients JAMA Internal Medicine. ,vol. 142, pp. 1663- 1667 ,(1982) , 10.1001/ARCHINTE.1982.00340220079015
JamesC. Wade, BrentG. Petty, Gary Conrad, CraigR. Smith, JamesJ. Lipsky, Jerrold Ellner, PaulS. Lietman, CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDE The Lancet. ,vol. 312, pp. 604- 606 ,(1978) , 10.1016/S0140-6736(78)92825-8
JAMES C WADE, STEPHEN C SCHIMPFF, KATHRYN A NEWMAN, PETER H WIERNIK, Staphylococcus epidermidis: An Increasing Cause of Infection in Patients with Granulocytopenia Annals of Internal Medicine. ,vol. 97, pp. 503- 508 ,(1982) , 10.7326/0003-4819-97-4-503
Lary J. Kilton, Byron E. Fossieck, Martin H. Cohen, Richard H. Parker, Bacteremia due to gram-positive cocci in patients with neoplastic disease The American Journal of Medicine. ,vol. 66, pp. 596- 602 ,(1979) , 10.1016/0002-9343(79)91169-0